Merck Sharp & Dohme Corp.
147 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 29 name spellings.
Previously recorded as Trius Therapeutics, Inc. (to 2016)
484
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 8 fees due Dec 2 to 30, 2026 · next Dec 2
- 24 fees due Jan 2 to 28, 2027 · next Jan 2
- 18 fees due Feb 4 to 27, 2027 · next Feb 4
- 28 fees due Mar 1 to 29, 2027 · next Mar 1
- 26 fees due Apr 1 to 30, 2027 · next Apr 1
- 22 fees due May 3 to 28, 2027 · next May 3
- 28 fees due Jun 1 to 30, 2027 · next Jun 1
- 35 fees due Jul 5 to 30, 2027 · next Jul 5
- 19 fees due Aug 4 to 25, 2027 · next Aug 4
- 28 fees due Sep 1 to 30, 2027 · next Sep 1
- 20 fees due Oct 5 to 30, 2027 · next Oct 5
- 19 fees due Nov 3 to 17, 2027 · next Nov 3
Recent changes
- 19 of the patents on this record were granted since Aug 23, 2026
- Nov 10 US 12,790,312 Plasma Kallikrein Inhibitors
- Nov 3 US 12,782,372 Robot Task Scheduler with Verified Audit Trail
- Nov 3 US 12,780,845 Arginase Inhibitors and Methods of Use
- Oct 27 US 12,773,448 Compositions Comprising Streptococcus Pneumoniae Polysaccharide-Protein Conjugates and Methods of Use Thereof
- Oct 27 US 12,773,391 Lipid Nanoparticle Compositions Containing Monoester Cationic Lipids
- Oct 13 US 12,760,037 Plasma Kallikrein Inhibitors
- Oct 13 US 12,760,026 Heteroaroyl Amides as LRRK2 Inhibitors, Pharmaceutical Compositions, and Uses Thereof
- Oct 13 US 12,760,005 Bicycloheptane Pyrrolidine Orexin Receptor Agonists
- Oct 6 US 12,753,190 Spirotricycle RIPK1 Inhibitors and Methods of Uses Thereof
- Oct 6 US 12,753,187 Amido-Substituted Pyridyl Compounds and Methods of Use Thereof for the Treatment of Herpesviruses
- Oct 6 US 12,753,163 Diaminopyrimidine Carboxamide Inhibitors of HPK1
- Sep 29 US 12,747,244 Synthesis of BTK Inhibitor and Intermediates Thereof
- Sep 15 US 12,735,506 Arginase 1 Binders for Inhibiting Arginase 1 Activity
- Sep 15 US 12,735,431 7-Phenyl Substituted 2-Aminoquinazoline Inhibitors of HPK1
- Sep 15 US 12,735,425 6,7-Dihydro-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT
- 48 terms have ended since Aug 23, 2026
- Nov 19 US 7,816,380 1-Hydroxycycloalkanecarboxamide Derivatives · term ended
- Nov 10 US 8,003,653 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease · term ended
- Oct 28 US 8,871,929 Fused-Imidazoyl Compounds Useful as Antimicrobial Agents · lapsed on the fee record
- Oct 28 US 8,871,738 Fused Bicyclic Oxazolidinone Cetp Inhibitor · lapsed on the fee record
- Oct 25 US 8,895,560 Novel Opioid Antagonists · term ended
- Oct 25 US 8,580,788 Novel Opioid Antagonists · term ended
- Oct 25 US 8,202,854 Heterocyclic Aspartyl Protease Inhibitors · term ended
- Oct 25 US 8,012,960 Heterocyclic Aspartyl Protease Inhibitors · term ended
- Oct 25 US 7,700,103 Optimized Expression of HPV 52 L1 in Yeast · term ended
- Oct 23 US 7,872,024 Benzothiophene Hydroxamic Acid Derivatives with Carbamate, Urea, Amide and Sulfonamide Substitutions · term ended
- Oct 23 US 7,772,238 Benzothiophene Hydroxamic Acid Derivatives · term ended
- Oct 21 US 8,865,707 Cholesteryl Ester Transfer Protein Inhibitors · lapsed on the fee record
- Oct 21 US 8,865,701 Spiropyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease · lapsed on the fee record
- Oct 17 US 7,488,752 Thrombin Receptor Antagonists · term ended
- Oct 14 US 8,861,811 System and Method for Segmenting M-Mode Ultrasound Images Showing Blood Vessel Wall Motion Over Time · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,569,592 | Heteroaryl Substituted Pyrazole Modulators of Metabotropic Glutamate RECEPTOR-5 In force · High confidence | In force | High confidence | |
| US 7,625,938 | Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use In force · High confidence | In force | High confidence | |
| US 8,486,983 | Self-Emulsifying Formulations of Cetp Inhibitors In force · High confidence | In force | High confidence | |
| US 7,528,132 | Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 8,298,543 | Identification and Application of Antibiotic Synergy In force · High confidence | In force | High confidence | |
| US 7,888,369 | Oxazoloisoquinoline Derivatives as Thrombin Receptor Antagonists In force · High confidence | In force | High confidence | |
| US 7,547,720 | Ophthalmic Compositions for Treating Ocular Hypertension In force · High confidence | In force | High confidence | |
| US 7,709,658 | Process for Synthesizing a Substituted Pyrazole In force · High confidence | In force | High confidence | |
| US 7,834,026 | Spirocyclic Compounds In force · High confidence | In force | High confidence | |
| US 8,119,652 | Aryl-Fused Spirocyclic Compounds In force · High confidence | In force | High confidence |
Also on record, not counted in the 1,737: 147 patents in force now held by others · 1,263 lapsed for an unpaid fee · 1,403 ended at full term · 6 past the fee grace period · 4 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
226 pending · 496 abandoned · 26 no status recorded
Showing 1 to 10 of 748, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/302,594 | Substituted Amino Triazolopyrimidine and Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions and Their Use | Aug 18, 2025 | Pending |
| 19/268,323 | Labeling Shell for a Drug Vial | Jul 14, 2025 | Pending |
| 19/254,522 | Substituted Amino Triazolopyrimidine and Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions and Their Use | Jun 30, 2025 | Pending |
| 19/250,874 | Antibody Neutralizing Human Respiratory Syncytial Virus | Jun 26, 2025 | Pending |
| 19/226,799 | Anti-Cancer Combination Therapies Comprising CTLA-4 and PD-1 Blocking Agents | Jun 3, 2025 | Pending |
| 19/194,690 | Biomarkers for Cancer Therapeutics | Apr 30, 2025 | Pending |
| 19/082,466 | Pyridinone Derivatives as Selective Cytotoxic Agents Against Hiv Infected Cells | Mar 18, 2025 | Pending |
| 19/080,665 | System for Medicinal Supply Monitoring and Management for Pooled Medicinal Product Across Studies | Mar 14, 2025 | Pending |
| 19/080,658 | System for Medicinal Supply Monitoring and Management with Controlled Packaging of Medicinal Product | Mar 14, 2025 | Pending |
| 19/080,640 | System for Medicinal Supply Monitoring and Management with Digital Display Labeling | Mar 14, 2025 | Pending |
10 of 748 applications shown.
Pro members see all 748 published applications.